Canine Parvovirus Monoclonal Antibody

Canine Parvovirus Monoclonal Antibody is the first and only USDA-conditionally approved monoclonal antibody (mAb) treatment that targets canine parvovirus (CPV).

Why choose Canine Parvovirus Monoclonal Antibody? 

We anticipate Canine Parvovirus Monoclonal Antibody will help greatly decrease the burden of supportive care for CPV. You may be able to save days of labor and stress associated with managing the symptoms of this potentially deadly disease.

  • Blue map pin icon placed within circle to demonstrate targeted treatment of parvovirus.
    mAb that targets parvovirus directly

  • Blue droplet icon with a number 1 inside it to demonstrate product is single dose.
    Single-dose efficacy

  • Icon of blue clipboard with checklist on it to suggest official product information.
    High safety profile

  • Blue stethoscope icon
    May help decrease burden of supportive care and may help reduce emotional stress

Dosing Information

How Canine Parvovirus Monoclonal Antibody Works

Two components. One powerful product.

Canine Parvovirus Monoclonal Antibody is composed of a dog constant region and a rat variable region.

These two elements work together to neutralize canine parvovirus in vivo by selectively binding and blocking the virus from entering and destroying enterocytes.

Canine Parvovirus Monoclonal Antibody Resources

Animated scene of several canine parvoviruses and cells in a dog's body with words "Canine Parvovirus" across the middle.

Canine Parvovirus Disease State

Take charge of parvovirus

Now you can treat parvo, not just manage the symptoms. Contact your Elanco sales representative for more information on product availability or call us at 1-888-545-5973.

Parvovirus FAQs

Always read, understand and follow the label and use directions.